Saratov JOURNAL of Medical and Scientific Research

Combination of the transurethral resection and prostate HIFU ablation at treatment of the localized cancer

Year: 2014, volume 10 Issue: №3 Pages: 450-455
Heading: Urology Article type: Original article
Authors: Popkov V.M., Fomkin R.N., Blyumberg B.l., Shatylko T.V., Sedova L.N., Abramova E.P.
Organization: Saratov State Medical University
Summary:

Research objective: to estimate results of treatment of patients with the localized form of a cancer of a prostate at a combination of a transurethral resection (TURP) and HIFU of an ablation. Objects and research methods: From February, 2009 to February, 2014 of 100 patients with the localized form of a cancer of a prostate were selected for research:
26 patients were included into HIFU and 74 group in group of the combined treatment (TURP+HIFU). Selection criteria for HIFU ablation were the localized cancer of a prostate concerning which earlier it wasn't carried out treatments, and level of a PSA at the time of statement of the diagnosis 15 ng/ml. All patients corresponding to these by criteria, were considered as candidates for treatment and inclusion in the analysis. The nadir and stability of PSA, the histologic conclusion, IPSS, quality of life and complication were estimated at time of postoperative supervision. Results: Statistically significant influence of a combination TURP+HIFU for the term of transurethral drainage of a bladder (a median of 40 days against 7 days), incontience frequency (15.4% against 6.9%), infections of urinary ways (47.9% against 11.4%) and IPSS change during the postoperative period (on the average 8.91 against 3.37) is noted. During the short period of supervision it wasn't observed considerable changes in relation to efficiency: in HIFU group the frequency of repeated sessions made 25%, in TUR/HIFU group 4%. Conclusion: HIFU therapy is modern, minimum invasive method of a cancer therapy of a prostate. The combination of a transurethral resection and HIFU ablation significantly reduces the frequency of the complications connected with treatment. Maintaining the patient after combined TURP and HIFU ablation is comparable with maintaining the patient after usual TURP.

Bibliography:
1. Popkov V.M., Fomkin R.N., Blumberg B.l. Prognostic factors in the estimation of efficiency of results treatments sick of the localized cancer of the prostate by means of HIFU. Saratov Journal of Medical Scientific Research 2013; (1): 116-121
2. Popkov V.M., Fomkin R.N., Blumberg B.l. Postoperative monitoring of prostate-specific antigen (PSA) after treatment by the high-intensive focused ultrasound (HIFU). Saratov Journal of Medical Scientific Research 2012; (4): 1001-1007
3. D'Amico AV, Whittington R, Malkowicz SB, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998; 50 (3): 969-974
4. Popkov V.M., Fomkin R.N., Blumberg B.l. Possibilities of forecasting of relapse of the cancer prostate after HIFU ablation by means of mathematical modelling. Saratov Journal of Medical Scientific Research 2013; (9): 314-320
5. Glybochko P.V., Fomkin R.N., Blumberg B.l. High-intensity focused ultrasound in treatment of elderly and senile patients with prostate cancer. Clinical gerontology 2011; (9): 27-33
6. Fomkin R.N., Voronina E.S., Popkov V.M., et al. Patomorfoz of a prostate cancer at treatment by the high-intensity focused ultrasound (HIFU). Oncourology 2013; (1): 55-62
7. Fomkin R.N., Popkov V.M., Blumberg B.l. Comparative assessment of postoperative complications after single and repeated HIFU ablation the localized prostate cancer. Medical messenger of Bashkortostan 2013; (2): 222-226.ral medical Journal 2012; (3): 48-52
9. Fomkin RN, Voronina ES, Popkov VM, et al. Three-year results of treatment of the localized cancer of a prostate the high-intensity focused ultrasound. Urology 2014; (1): 37-44
10. Fomkin R.N., Voronina E.S., Popkov V.M., et al. Predictive value of molecular and biological, morphological and clinical markers in an assessment of efficiency of treatment of the localized cancer of a prostate the high-intensity focused ultrasound. Experimental and clinical urology 2013; (4): 29-33.

AttachmentSize
2014_03_450-455.pdf393.12 KB

No votes yet